About Themis Medicare Limited
Data last updated: 23 December 2025
Themis Medicare Limited is a public limited company based in Vapi, Gujarat, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 31 May 1969, the company has been in operation for over 57 years.
Registered with ROC Ahmedabad under CIN L24110GJ1969PLC001590. Listed on BSE: 530199 and NSE: THEMISMED.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.21 Cr. It is led by directors including Pradeep Manjunath Chandan and Reena Sachin Patel.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No 69 – A Gidc Ind Estate Dist – Valsad, Vapi, Gujarat, India – 396195.
As per the financials filed for FY 2025, the company reported a revenue of ₹410.18 Cr, a growth of 6% compared to the previous year.
The company has a workforce of approximately 1,343 employees as per the latest available data. Its group structure includes 2 subsidiaries and 1 joint venture.
The company is associated with 1 brand - Themis Medicare. As per MCA filings, the company has open charges of ₹577.29 Cr and satisfied charges of ₹110.37 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website themismedicare.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressPlot No 69 – A Gidc Ind Estate Dist – Valsad, Vapi, Gujarat, India – 396195
-
IndustryPharma, API Manufacturers, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Themis Medicare Limited
Themis Medicare Limited operates one associated brand: Themis Medicare. These brands represent Themis Medicare Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products for pain management and critical care are manufactured. | themismedicare.com |
Business Activity of Themis Medicare Limited
Themis Medicare Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Themis Medicare Limited
Themis Medicare Limited is audited by KRISHAAN AND CO (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| KRISHAAN AND CO (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Themis Medicare Limited
Themis Medicare Limited is currently managed by 12 directors, with 26 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of Themis Medicare Limited FY 2026 filings available
Themis Medicare Limited reported revenue of ₹342.24 Cr (down 15.6% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹342.24 Cr | ₹405.51 Cr | ₹381.76 Cr | ₹354.32 Cr | ₹394.61 Cr | ₹230.67 Cr | ₹201.59 Cr |
| Other Income | ₹9.36 Cr | ₹4.67 Cr | ₹4.76 Cr | ₹11.5 Cr | ₹6.54 Cr | ₹3.62 Cr | ₹3.46 Cr |
| Total Income | ₹351.6 Cr | ₹410.18 Cr | ₹386.52 Cr | ₹365.83 Cr | ₹401.16 Cr | ₹234.29 Cr | ₹205.05 Cr |
| Cost of Materials Consumed | ₹57.3 Cr | ₹76.31 Cr | ₹84.67 Cr | ₹96.04 Cr | ₹113.63 Cr | ₹67.92 Cr | ₹51.38 Cr |
| Purchases of Stock-in-Trade | ₹63 Cr | ₹73.67 Cr | ₹53.61 Cr | ₹30.12 Cr | ₹31.45 Cr | ₹11.55 Cr | ₹15.3 Cr |
| Changes in Inventories | ₹9.17 Cr | -₹17.98 Cr | -₹1.57 Cr | -₹7.79 Cr | ₹3.06 Cr | -₹90.29 Lakh | -₹3.49 Cr |
| Employee Benefit Expense | ₹93.52 Cr | ₹96.38 Cr | ₹82.41 Cr | ₹66.15 Cr | ₹51.97 Cr | ₹39.99 Cr | ₹44.28 Cr |
| Finance Costs | ₹10.69 Cr | ₹10.04 Cr | ₹9.38 Cr | ₹9.56 Cr | ₹8.77 Cr | ₹12.71 Cr | ₹12.88 Cr |
| Depreciation & Amortisation | ₹10.32 Cr | ₹9.93 Cr | ₹12.25 Cr | ₹10.49 Cr | ₹9.48 Cr | ₹8.55 Cr | ₹8.27 Cr |
| Other Expenses | ₹118.85 Cr | ₹128.1 Cr | ₹111.13 Cr | ₹102.36 Cr | ₹98.87 Cr | ₹62.61 Cr | ₹58.47 Cr |
| Total Expenses | ₹362.85 Cr | ₹376.43 Cr | ₹351.88 Cr | ₹306.93 Cr | ₹317.23 Cr | ₹202.44 Cr | ₹187.08 Cr |
| Profit Before Exceptional Items & Tax | -₹11.25 Cr | ₹33.75 Cr | ₹34.64 Cr | ₹58.9 Cr | ₹83.92 Cr | ₹31.86 Cr | ₹17.97 Cr |
| Exceptional Items | -₹86.53 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹12.12 Cr | ₹33.75 Cr | ₹34.64 Cr | ₹58.9 Cr | ₹83.92 Cr | ₹31.86 Cr | ₹17.97 Cr |
| Total Tax Expense | ₹78.45 Lakh | ₹9.84 Cr | ₹9.92 Cr | ₹15.61 Cr | ₹22.38 Cr | ₹5.63 Cr | ₹2.09 Cr |
| Net Profit | ₹1.14 Cr | ₹29.83 Cr | ₹43.52 Cr | ₹56.9 Cr | ₹72.88 Cr | ₹35.7 Cr | ₹24.78 Cr |
| attributable to Owners | ₹1.14 Cr | ₹29.83 Cr | ₹43.52 Cr | ₹56.9 Cr | ₹72.88 Cr | ₹35.7 Cr | ₹24.78 Cr |
| attributable to NCI | -₹2,000 | -₹2,000 | -₹3,000 | -₹2,000 | -₹1,000 | -₹1,000 | -₹1,000 |
| Other Comprehensive Income | -₹68.75 Lakh | -₹29.65 Lakh | -₹73.96 Lakh | -₹43.14 Lakh | -₹33.82 Lakh | -₹40.71 Lakh | -₹7.13 Lakh |
| Total Comprehensive Income | ₹45.62 Lakh | ₹29.54 Cr | ₹42.78 Cr | ₹56.47 Cr | ₹72.54 Cr | ₹35.3 Cr | ₹24.71 Cr |
| EBITDA (computed) | ₹9.75 Cr | ₹53.72 Cr | ₹56.26 Cr | ₹78.96 Cr | ₹102.18 Cr | ₹53.12 Cr | ₹39.12 Cr |
| Basic EPS | ₹0.12 | ₹3.24 | ₹4.73 | ₹61.83 | ₹79.22 | ₹38.86 | ₹26.97 |
| Diluted EPS | ₹0.12 | ₹3.24 | ₹4.72 | ₹61.73 | ₹79.07 | ₹38.84 | ₹26.97 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹597.91 Cr | ₹588.03 Cr | ₹566.42 Cr | ₹513.96 Cr |
| Non-current Assets | ₹292.93 Cr | ₹284.17 Cr | ₹273.25 Cr | ₹249.43 Cr |
| Current Assets | ₹304.98 Cr | ₹303.87 Cr | ₹293.17 Cr | ₹264.53 Cr |
| Property, Plant & Equipment | ₹166.4 Cr | ₹172.03 Cr | ₹167.81 Cr | ₹160.98 Cr |
| Inventories | ₹81.09 Cr | ₹84.31 Cr | ₹70.57 Cr | ₹68.95 Cr |
| Trade Receivables | ₹178.12 Cr | ₹177.1 Cr | ₹177.95 Cr | ₹145.02 Cr |
| Cash & Equivalents | ₹4.54 Cr | ₹6.56 Cr | ₹9.92 Cr | ₹12.55 Cr |
| Equity (Net Worth) | ₹398.58 Cr | ₹402.6 Cr | ₹377.67 Cr | ₹339.44 Cr |
| Equity Share Capital | ₹9.21 Cr | ₹9.2 Cr | ₹9.2 Cr | ₹9.2 Cr |
| Borrowings (Non-current) | ₹21.86 Cr | ₹18.61 Cr | ₹26.77 Cr | ₹28.45 Cr |
| Borrowings (Current) | ₹78.23 Cr | ₹64.38 Cr | ₹69.02 Cr | ₹63.51 Cr |
| Total Debt (computed) | ₹100.09 Cr | ₹82.99 Cr | ₹95.79 Cr | ₹91.96 Cr |
| Current Liabilities | ₹166.16 Cr | ₹156.12 Cr | ₹154.58 Cr | ₹139.13 Cr |
| Total Liabilities | ₹199.33 Cr | ₹185.43 Cr | ₹188.75 Cr | ₹174.51 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹3.27 Cr | ₹34.71 Cr | ₹14.47 Cr | ₹16.09 Cr | ₹34.39 Cr |
| Investing Cash Flow | -₹2.54 Cr | -₹12.17 Cr | -₹15.95 Cr | -₹23.96 Cr | -₹15.23 Cr |
| Financing Cash Flow | ₹3.79 Cr | -₹25.9 Cr | -₹1.14 Cr | ₹13.62 Lakh | -₹17.55 Cr |
| Capital Expenditure | ₹4.87 Cr | ₹15.43 Cr | ₹18.42 Cr | ₹28.75 Cr | ₹20.27 Cr |
| Free Cash Flow (computed) | -₹8.14 Cr | ₹19.28 Cr | -₹3.95 Cr | -₹12.66 Cr | ₹14.13 Cr |
| Dividends Paid | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹3.96 Cr |
| Net Change in Cash | -₹2.02 Cr | -₹3.36 Cr | -₹2.62 Cr | -₹7.73 Cr | ₹1.62 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹76.53 Cr | ₹90.13 Cr | ₹77.99 Cr | ₹97.58 Cr | ₹71.7 Cr | ₹93.81 Cr | ₹117.01 Cr | ₹122.99 Cr | ₹97.82 Cr | ₹82.51 Cr | ₹104.78 Cr | ₹96.65 Cr |
| Other Income | ₹3.67 Cr | ₹1.28 Cr | ₹3.24 Cr | ₹1.18 Cr | ₹1.55 Cr | ₹1.02 Cr | ₹1.14 Cr | ₹95.85 Lakh | ₹1.1 Cr | ₹56.49 Lakh | ₹2.44 Cr | ₹65.29 Lakh |
| Total Income | ₹80.2 Cr | ₹91.42 Cr | ₹81.23 Cr | ₹98.75 Cr | ₹73.25 Cr | ₹94.83 Cr | ₹118.15 Cr | ₹123.95 Cr | ₹98.92 Cr | ₹83.08 Cr | ₹107.22 Cr | ₹97.3 Cr |
| Cost of Materials Consumed | ₹14.27 Cr | ₹14.5 Cr | ₹16.11 Cr | ₹12.43 Cr | ₹18.98 Cr | ₹12.76 Cr | ₹21.06 Cr | ₹23.52 Cr | ₹21.65 Cr | ₹21.13 Cr | ₹26.18 Cr | ₹15.71 Cr |
| Purchases of Stock-in-Trade | ₹11.46 Cr | ₹11.63 Cr | ₹18.23 Cr | ₹21.68 Cr | ₹16.3 Cr | ₹22.51 Cr | ₹18.12 Cr | ₹16.74 Cr | ₹11.79 Cr | ₹18.11 Cr | ₹13.92 Cr | ₹9.79 Cr |
| Changes in Inventories | -₹1.98 Cr | ₹3.05 Cr | -₹10.19 Cr | ₹18.29 Cr | -₹14.68 Cr | -₹6.77 Cr | ₹2.46 Cr | ₹1.01 Cr | ₹5.78 Cr | -₹12.77 Cr | ₹1.84 Cr | ₹3.57 Cr |
| Employee Benefit Expense | ₹21.06 Cr | ₹22.68 Cr | ₹24.93 Cr | ₹24.85 Cr | ₹25.45 Cr | ₹24.95 Cr | ₹24.38 Cr | ₹21.6 Cr | ₹22.46 Cr | ₹19.92 Cr | ₹19.86 Cr | ₹20.17 Cr |
| Finance Costs | ₹2.7 Cr | ₹2.75 Cr | ₹2.76 Cr | ₹2.47 Cr | ₹2.45 Cr | ₹2.79 Cr | ₹2.44 Cr | ₹2.36 Cr | ₹2.16 Cr | ₹2.68 Cr | ₹2.04 Cr | ₹2.49 Cr |
| Depreciation & Amortisation | ₹2.6 Cr | ₹2.59 Cr | ₹2.57 Cr | ₹2.55 Cr | ₹2.53 Cr | ₹2.54 Cr | ₹2.45 Cr | ₹2.41 Cr | ₹3.06 Cr | ₹3.1 Cr | ₹3.07 Cr | ₹3.03 Cr |
| Other Expenses | ₹27.96 Cr | ₹28.48 Cr | ₹32.01 Cr | ₹30.41 Cr | ₹31.45 Cr | ₹31.83 Cr | ₹33.87 Cr | ₹30.95 Cr | ₹26.83 Cr | ₹28.05 Cr | ₹30.58 Cr | ₹25.67 Cr |
| Total Expenses | ₹78.07 Cr | ₹85.68 Cr | ₹86.42 Cr | ₹112.68 Cr | ₹82.47 Cr | ₹90.61 Cr | ₹104.78 Cr | ₹98.58 Cr | ₹93.74 Cr | ₹80.23 Cr | ₹97.48 Cr | ₹80.43 Cr |
| Profit Before Exceptional Items & Tax | ₹2.13 Cr | ₹5.74 Cr | -₹5.19 Cr | -₹13.93 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹13.37 Cr | ₹25.37 Cr | ₹5.18 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Exceptional Items | ₹0 | -₹86.53 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹2.13 Cr | ₹4.87 Cr | -₹5.19 Cr | -₹13.93 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹13.37 Cr | ₹25.37 Cr | ₹5.18 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Total Tax Expense | ₹17.02 Lakh | ₹29.42 Lakh | ₹16.49 Lakh | ₹15.52 Lakh | -₹1.46 Cr | ₹1.14 Cr | ₹3.5 Cr | ₹6.66 Cr | ₹2.11 Cr | ₹85.05 Lakh | ₹2.64 Cr | ₹4.32 Cr |
| Net Profit | ₹8.89 Cr | ₹10.09 Cr | -₹3.62 Cr | -₹14.22 Cr | -₹9.66 Cr | ₹51.93 Lakh | ₹14.29 Cr | ₹24.68 Cr | ₹6.64 Cr | ₹7.37 Cr | ₹11.32 Cr | ₹18.19 Cr |
| attributable to Owners | ₹8.89 Cr | ₹10.09 Cr | -₹3.62 Cr | -₹14.25 Cr | -₹9.66 Cr | ₹51.93 Lakh | ₹0 | ₹24.68 Cr | ₹6.64 Cr | ₹7.37 Cr | ₹11.32 Cr | ₹18.19 Cr |
| attributable to NCI | -₹1,000 | ₹0 | ₹0 | -₹1,000 | -₹1,000 | ₹0 | ₹0 | -₹1,000 | -₹3,000 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹6.04 Lakh | -₹52.51 Lakh | -₹7.41 Lakh | -₹2.8 Lakh | -₹23.06 Lakh | -₹3.84 Lakh | ₹15.86 Lakh | -₹18.61 Lakh | -₹42.49 Lakh | -₹10.48 Lakh | -₹9.81 Lakh | -₹11.18 Lakh |
| Total Comprehensive Income | ₹8.83 Cr | ₹9.57 Cr | -₹3.69 Cr | -₹14.25 Cr | -₹9.9 Cr | ₹48.09 Lakh | ₹14.45 Cr | ₹24.5 Cr | ₹6.22 Cr | ₹7.26 Cr | ₹11.22 Cr | ₹18.08 Cr |
| EBITDA (computed) | ₹7.43 Cr | ₹11.08 Cr | ₹14.88 Lakh | -₹8.91 Cr | -₹4.23 Cr | ₹9.55 Cr | ₹18.27 Cr | ₹30.13 Cr | ₹10.4 Cr | ₹8.63 Cr | ₹14.84 Cr | ₹22.39 Cr |
| Basic EPS | ₹0.96 | ₹1.10 | ₹-0.39 | ₹-1.54 | ₹-1.05 | ₹0.06 | ₹1.55 | ₹2.68 | ₹0.72 | ₹0.80 | ₹12.30 | ₹19.77 |
| Diluted EPS | ₹0.96 | ₹1.09 | ₹-0.39 | ₹-1.54 | ₹-1.05 | ₹0.06 | ₹1.55 | ₹2.68 | ₹0.72 | ₹0.80 | ₹12.28 | ₹19.73 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹342.24 Cr | ₹405.51 Cr | ₹381.76 Cr | ₹354.32 Cr | ₹394.61 Cr | ₹230.67 Cr | ₹201.59 Cr |
| Other Income | ₹9.36 Cr | ₹4.67 Cr | ₹4.76 Cr | ₹11.5 Cr | ₹6.54 Cr | ₹3.62 Cr | ₹3.47 Cr |
| Total Income | ₹351.6 Cr | ₹410.18 Cr | ₹386.52 Cr | ₹365.83 Cr | ₹401.16 Cr | ₹234.29 Cr | ₹205.06 Cr |
| Cost of Materials Consumed | ₹57.3 Cr | ₹76.31 Cr | ₹84.67 Cr | ₹96.04 Cr | ₹113.63 Cr | ₹67.92 Cr | ₹51.38 Cr |
| Purchases of Stock-in-Trade | ₹63 Cr | ₹73.67 Cr | ₹53.61 Cr | ₹30.12 Cr | ₹31.45 Cr | ₹11.55 Cr | ₹15.3 Cr |
| Changes in Inventories | ₹9.17 Cr | -₹17.98 Cr | -₹1.57 Cr | -₹7.79 Cr | ₹3.06 Cr | -₹1.27 Cr | -₹3.49 Cr |
| Employee Benefit Expense | ₹93.52 Cr | ₹96.38 Cr | ₹82.41 Cr | ₹66.15 Cr | ₹51.97 Cr | ₹39.99 Cr | ₹44.28 Cr |
| Finance Costs | ₹10.69 Cr | ₹10.04 Cr | ₹9.38 Cr | ₹9.56 Cr | ₹8.77 Cr | ₹12.71 Cr | ₹12.88 Cr |
| Depreciation & Amortisation | ₹10.32 Cr | ₹9.93 Cr | ₹12.25 Cr | ₹10.49 Cr | ₹9.48 Cr | ₹8.55 Cr | ₹8.27 Cr |
| Other Expenses | ₹118.84 Cr | ₹128.08 Cr | ₹111.1 Cr | ₹102.35 Cr | ₹98.85 Cr | ₹62.59 Cr | ₹58.45 Cr |
| Total Expenses | ₹362.84 Cr | ₹376.42 Cr | ₹351.85 Cr | ₹306.92 Cr | ₹317.22 Cr | ₹202.04 Cr | ₹187.05 Cr |
| Profit Before Exceptional Items & Tax | -₹11.24 Cr | ₹33.76 Cr | ₹34.67 Cr | ₹58.91 Cr | ₹83.94 Cr | ₹32.25 Cr | ₹18.01 Cr |
| Exceptional Items | -₹2.16 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹13.4 Cr | ₹33.76 Cr | ₹34.67 Cr | ₹58.91 Cr | ₹83.94 Cr | ₹32.25 Cr | ₹18.01 Cr |
| Total Tax Expense | ₹78.45 Lakh | ₹9.84 Cr | ₹9.92 Cr | ₹15.61 Cr | ₹22.38 Cr | ₹5.63 Cr | ₹2.09 Cr |
| Net Profit | -₹14.19 Cr | ₹23.92 Cr | ₹24.75 Cr | ₹43.29 Cr | ₹61.56 Cr | ₹26.62 Cr | ₹15.91 Cr |
| Other Comprehensive Income | -₹73.52 Lakh | -₹30.9 Lakh | -₹73.68 Lakh | -₹43.36 Lakh | -₹31.87 Lakh | -₹31.85 Lakh | -₹8.36 Lakh |
| Total Comprehensive Income | -₹14.92 Cr | ₹23.61 Cr | ₹24.01 Cr | ₹42.86 Cr | ₹61.24 Cr | ₹26.3 Cr | ₹15.83 Cr |
| EBITDA (computed) | ₹9.77 Cr | ₹53.73 Cr | ₹56.29 Cr | ₹78.97 Cr | ₹102.19 Cr | ₹53.51 Cr | ₹39.15 Cr |
| Basic EPS | ₹-1.54 | ₹2.60 | ₹2.69 | ₹47.05 | ₹66.91 | ₹28.97 | ₹17.32 |
| Diluted EPS | ₹-1.54 | ₹2.59 | ₹2.68 | ₹46.97 | ₹66.78 | ₹28.97 | ₹17.32 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹500.21 Cr | ₹505.65 Cr | ₹489.97 Cr | ₹456.29 Cr |
| Non-current Assets | ₹195.22 Cr | ₹200.5 Cr | ₹195.52 Cr | ₹190.49 Cr |
| Current Assets | ₹304.99 Cr | ₹305.15 Cr | ₹294.44 Cr | ₹265.8 Cr |
| Property, Plant & Equipment | ₹166.4 Cr | ₹172.03 Cr | ₹167.81 Cr | ₹160.97 Cr |
| Inventories | ₹81.09 Cr | ₹84.31 Cr | ₹70.57 Cr | ₹68.95 Cr |
| Trade Receivables | ₹178.12 Cr | ₹177.46 Cr | ₹178.3 Cr | ₹145.38 Cr |
| Cash & Equivalents | ₹4.45 Cr | ₹6.47 Cr | ₹9.83 Cr | ₹12.51 Cr |
| Equity (Net Worth) | ₹300.95 Cr | ₹320.29 Cr | ₹301.28 Cr | ₹281.83 Cr |
| Equity Share Capital | ₹9.21 Cr | ₹9.2 Cr | ₹9.2 Cr | ₹9.2 Cr |
| Borrowings (Non-current) | ₹21.86 Cr | ₹18.61 Cr | ₹26.77 Cr | ₹28.45 Cr |
| Borrowings (Current) | ₹78.23 Cr | ₹64.38 Cr | ₹69.02 Cr | ₹63.51 Cr |
| Total Debt (computed) | ₹100.09 Cr | ₹82.99 Cr | ₹95.79 Cr | ₹91.96 Cr |
| Current Liabilities | ₹166.1 Cr | ₹156.06 Cr | ₹154.52 Cr | ₹139.07 Cr |
| Total Liabilities | ₹199.26 Cr | ₹185.37 Cr | ₹188.69 Cr | ₹174.46 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹3.27 Cr | ₹34.71 Cr | ₹22.04 Cr | ₹16.07 Cr | ₹34.39 Cr |
| Investing Cash Flow | -₹2.54 Cr | -₹12.17 Cr | -₹15.96 Cr | -₹23.96 Cr | -₹15.58 Cr |
| Financing Cash Flow | ₹3.79 Cr | -₹25.9 Cr | -₹8.77 Cr | ₹13.62 Lakh | -₹17.55 Cr |
| Capital Expenditure | ₹4.87 Cr | ₹15.43 Cr | ₹18.42 Cr | ₹28.75 Cr | ₹20.63 Cr |
| Free Cash Flow (computed) | -₹8.14 Cr | ₹19.28 Cr | ₹3.63 Cr | -₹12.68 Cr | ₹13.77 Cr |
| Dividends Paid | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹3.96 Cr |
| Net Change in Cash | -₹2.02 Cr | -₹3.36 Cr | -₹2.68 Cr | -₹7.75 Cr | ₹1.26 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹76.53 Cr | ₹90.13 Cr | ₹77.99 Cr | ₹97.58 Cr | ₹71.7 Cr | ₹93.81 Cr | ₹99.59 Cr | ₹106.08 Cr | ₹97.82 Cr | ₹82.51 Cr | ₹104.78 Cr | ₹96.65 Cr |
| Other Income | ₹3.67 Cr | ₹1.28 Cr | ₹3.24 Cr | ₹1.18 Cr | ₹1.55 Cr | ₹1.02 Cr | ₹76.61 Lakh | ₹71.17 Lakh | ₹1.1 Cr | ₹56.49 Lakh | ₹2.44 Cr | ₹65.29 Lakh |
| Total Income | ₹80.2 Cr | ₹91.42 Cr | ₹81.23 Cr | ₹98.75 Cr | ₹73.25 Cr | ₹94.83 Cr | ₹100.36 Cr | ₹106.79 Cr | ₹98.92 Cr | ₹83.08 Cr | ₹107.22 Cr | ₹97.3 Cr |
| Cost of Materials Consumed | ₹14.27 Cr | ₹14.5 Cr | ₹16.11 Cr | ₹12.43 Cr | ₹18.98 Cr | ₹12.76 Cr | ₹11.37 Cr | ₹13.3 Cr | ₹21.65 Cr | ₹21.13 Cr | ₹26.18 Cr | ₹15.71 Cr |
| Purchases of Stock-in-Trade | ₹11.46 Cr | ₹11.63 Cr | ₹18.23 Cr | ₹21.68 Cr | ₹16.3 Cr | ₹22.51 Cr | ₹18.12 Cr | ₹16.74 Cr | ₹11.79 Cr | ₹18.11 Cr | ₹13.92 Cr | ₹9.79 Cr |
| Changes in Inventories | -₹1.98 Cr | ₹3.05 Cr | -₹10.19 Cr | ₹18.29 Cr | -₹14.68 Cr | -₹6.77 Cr | ₹2.91 Cr | ₹1.37 Cr | ₹5.78 Cr | -₹12.77 Cr | ₹1.84 Cr | ₹3.57 Cr |
| Employee Benefit Expense | ₹21.06 Cr | ₹22.68 Cr | ₹24.93 Cr | ₹24.85 Cr | ₹25.45 Cr | ₹24.95 Cr | ₹21.59 Cr | ₹18.87 Cr | ₹22.46 Cr | ₹19.92 Cr | ₹19.86 Cr | ₹20.17 Cr |
| Finance Costs | ₹2.7 Cr | ₹2.75 Cr | ₹2.76 Cr | ₹2.47 Cr | ₹2.45 Cr | ₹2.79 Cr | ₹1.6 Cr | ₹1.44 Cr | ₹2.16 Cr | ₹2.68 Cr | ₹2.04 Cr | ₹2.49 Cr |
| Depreciation & Amortisation | ₹2.6 Cr | ₹2.59 Cr | ₹2.57 Cr | ₹2.55 Cr | ₹2.53 Cr | ₹2.54 Cr | ₹1.06 Cr | ₹1.01 Cr | ₹3.06 Cr | ₹3.1 Cr | ₹3.07 Cr | ₹3.03 Cr |
| Other Expenses | ₹27.95 Cr | ₹28.48 Cr | ₹32.01 Cr | ₹30.41 Cr | ₹31.44 Cr | ₹31.83 Cr | ₹28.57 Cr | ₹26.55 Cr | ₹26.82 Cr | ₹28.04 Cr | ₹30.58 Cr | ₹25.66 Cr |
| Total Expenses | ₹78.06 Cr | ₹85.68 Cr | ₹86.42 Cr | ₹112.68 Cr | ₹82.46 Cr | ₹90.61 Cr | ₹85.23 Cr | ₹79.28 Cr | ₹93.72 Cr | ₹80.23 Cr | ₹97.48 Cr | ₹80.42 Cr |
| Profit Before Exceptional Items & Tax | ₹2.14 Cr | ₹5.74 Cr | -₹5.19 Cr | -₹13.92 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹15.13 Cr | ₹27.5 Cr | ₹5.2 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Exceptional Items | ₹0 | -₹86.53 Lakh | ₹0 | -₹1.29 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹2.14 Cr | ₹4.87 Cr | -₹5.19 Cr | -₹15.22 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹15.13 Cr | ₹27.5 Cr | ₹5.2 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Total Tax Expense | ₹17.02 Lakh | ₹29.42 Lakh | ₹16.49 Lakh | ₹15.52 Lakh | -₹1.46 Cr | ₹1.14 Cr | ₹3.95 Cr | ₹7.2 Cr | ₹2.11 Cr | ₹85.05 Lakh | ₹2.64 Cr | ₹4.32 Cr |
| Net Profit | ₹1.97 Cr | ₹4.58 Cr | -₹5.36 Cr | -₹15.37 Cr | -₹7.74 Cr | ₹3.08 Cr | ₹9.87 Cr | ₹18.71 Cr | ₹3.09 Cr | ₹2 Cr | ₹7.1 Cr | ₹12.56 Cr |
| Other Comprehensive Income | -₹6.13 Lakh | -₹51.94 Lakh | -₹7.72 Lakh | -₹7.73 Lakh | -₹25.2 Lakh | -₹1.9 Lakh | ₹14.62 Lakh | -₹18.42 Lakh | -₹41.17 Lakh | -₹10.83 Lakh | -₹10.85 Lakh | -₹10.83 Lakh |
| Total Comprehensive Income | ₹1.9 Cr | ₹4.06 Cr | -₹5.43 Cr | -₹15.45 Cr | -₹8 Cr | ₹3.06 Cr | ₹10.02 Cr | ₹18.53 Cr | ₹2.68 Cr | ₹1.89 Cr | ₹6.99 Cr | ₹12.45 Cr |
| EBITDA (computed) | ₹7.44 Cr | ₹11.08 Cr | ₹14.88 Lakh | -₹8.9 Cr | -₹4.23 Cr | ₹9.55 Cr | ₹17.79 Cr | ₹29.96 Cr | ₹10.41 Cr | ₹8.63 Cr | ₹14.85 Cr | ₹22.4 Cr |
| Basic EPS | ₹0.21 | ₹0.50 | ₹-0.58 | ₹-1.67 | ₹-0.84 | ₹0.33 | ₹1.22 | ₹2.20 | ₹0.34 | ₹0.22 | ₹7.71 | ₹13.64 |
| Diluted EPS | ₹0.21 | ₹0.50 | ₹-0.58 | ₹-1.67 | ₹-0.84 | ₹0.33 | ₹1.21 | ₹2.20 | ₹0.34 | ₹0.22 | ₹7.70 | ₹13.62 |
Shareholding Pattern of Themis Medicare Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 67.11%, foreign institutional investors hold 0.11%, domestic institutional investors hold 0.01%, retail and other public shareholders hold 32.78% of Themis Medicare Limited. The company had 21,818 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 67.11% | 67.11% | 67.15% | 67.15% | 67.15% | 67.15% |
| Public | 32.89% | 32.89% | 32.85% | 32.85% | 32.85% | 32.85% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 67.11% | 67.15% | 67.15% | 67.16% | 67.18% | 67.26% | 67.27% | 67.32% | 67.32% | 66.99% | 71.11% |
| Public | 32.89% | 32.85% | 32.85% | 32.84% | 32.82% | 32.74% | 32.73% | 32.68% | 32.68% | 33.01% | 28.89% |
| Promoter change (YoY, %pts) | -0.04 | +0.00 | -0.01 | -0.02 | -0.08 | -0.01 | -0.05 | +0.00 | +0.33 | -4.12 | - |
Board & Governance of Themis Medicare Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Themis Medicare Limited has 9 directors - 4 independent and 2 executive. The board is chaired by Dinesh Shantilal Patel.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Dinesh Shantilal Patel | Executive Director · Chairperson | 2007-06-29 | 2 |
| Sachin Dinesh Patel | Executive Director · CEO-MD | 2007-06-29 | 2 |
| Rajneesh Kedarnath Anand | Non-Executive - Non Independent Director | 2007-04-27 | 2 |
| Adam Demeter | Non-Executive - Non Independent Director | 2023-09-11 | 1 |
| Reena Sachin Patel | Alternate Director | 2023-09-11 | 1 |
| Bhaskar Vemban Iyer | Non-Executive - Independent Director | 2021-11-12 | 3 |
| Shishir Vasant Dalal | Non-Executive - Independent Director | 2023-09-11 | 3 |
| Nikunt Kirit Raval | Non-Executive - Independent Director | 2024-06-06 | 2 |
| Neha Anant Thakore | Non-Executive - Independent Director | 2025-08-01 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Shishir Vasant Dalal (Chairperson), Sachin Dinesh Patel, Bhaskar Vemban Iyer, Nikunt Kirit Raval |
| Nomination and remuneration committee | Shishir Vasant Dalal (Chairperson), Rajneesh Kedarnath Anand, Nikunt Kirit Raval |
| Stakeholders Relationship Committee | Nikunt Kirit Raval (Chairperson), Sachin Dinesh Patel, Rajneesh Kedarnath Anand, Bhaskar Vemban Iyer |
| Risk Management Committee | Sachin Dinesh Patel (Chairperson), Bhaskar Vemban Iyer, Neha Anant Thakore, Tushar Dalal |
| Corporate Social Responsibility Committee | Nikunt Kirit Raval (Chairperson), Sachin Dinesh Patel, Neha Anant Thakore |
| Allotment Committee | Dinesh Shantilal Patel (Chairperson), Sachin Dinesh Patel |
Group Structure of Themis Medicare Limited
Themis Medicare Limited has 2 subsidiary companies, 1 joint venture, and 2 associated companies. This group structure data is as of FY 2023. The corporate group structure reflects Themis Medicare Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Artemis Biotech Limited | U24233MH2011PLC212359 | - |
| Themis Chemicals Private Limited | U33111MH2010PTC209797 | - |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Themis Medicare Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2025 | Others | ₹1 Cr | Open |
| 22 Nov 2024 | Others | ₹11.25 Cr | Open |
| 22 Nov 2024 | Others | ₹5 Cr | Open |
| 30 Sep 2024 | Others | ₹12 Lakh | Open |
| 29 May 2024 | Others | ₹1.2 Cr | Open |
Total charge records: 46 View all charges
Employees and EPFO Compliance at Themis Medicare Limited
Themis Medicare Limited has a workforce of 1,343 employees as of Apr 07, 2024.
Employee Count & EPFO Data of Themis Medicare Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Themis Medicare Limited
GSTIN & GST Filing Data of Themis Medicare Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Themis Medicare Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Themis Medicare Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Themis Medicare Limited
MSME Payment Delays by Themis Medicare Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Themis Medicare Limited
Subsidiaries & Group Companies of Themis Medicare Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Themis Medicare Limited with ownership details.
MCA Filings & Documents of Themis Medicare Limited
MCA Filings & Documents of Themis Medicare Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Themis Medicare Limited
Recent News on Themis Medicare Limited
Frequently Asked Questions about Themis Medicare Limited
Themis Medicare Limited is an active public limited company in the pharma sector based in Vapi, Gujarat, India. It was incorporated on 31 May 1969 (57+ years old) and is registered under CIN L24110GJ1969PLC001590. Listed on BSE: 530199 and NSE: THEMISMED. The company has 1,343 employees.
Themis Medicare Limited reported revenue of ₹410.18 Cr for FY 2025 (up 6.00% YoY).
The current directors of Themis Medicare Limited are:
- Pradeep Manjunath Chandan
- Reena Sachin Patel
- Shishir Vasant Dalal
- Dr Adam Demeter
- Nikunt Kirit Raval
- Sachin Patel Dinesh
- Tushar Jayantilal Dalal
- Dinesh Shantilal Patel
- Neha Anant Thakore
- Rajneesh Kedarnath Anand
- Bhaskar Vemban Iyer
- Sachin Dinesh Patel
The primary industry of Themis Medicare Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Themis Medicare Limited is listed on both BSE (code: 530199) and NSE (symbol: THEMISMED).
Themis Medicare Limited can be reached at the registered office: Plot No 69 – A Gidc Ind Estate Dist – Valsad, Vapi, Gujarat, India – 396195, or through the website themismedicare.com.